Hepatocellular carcinoma in F0 livers: Clinical and prognostic insights

doi:10.4251/wjgo.v18.i4.115576

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 4

This Article

(29)

(23)

(0)

(16)

(567)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Gastrointest Oncol. Apr 15, 2026; 18(4): 115576
Published online Apr 15, 2026. doi: 10.4251/wjgo.v18.i4.115576

Full Size Figure Download Figure

Figure 1 Overall survival and recurrence-free survival of patients with F0 and F4 hepatocellular carcinoma. A: Overall survival. Kaplan-Meier analysis showed no significant difference in overall survival between F0 (nonfibrotic liver) and F4 (cirrhotic liver) hepatocellular carcinoma (P = 0.789); B: Recurrence-free survival. Recurrence was seen in 22 patients and 73 patients, respectively, in the F0 and F4 hepatocellular carcinoma groups, although recurrence-free survival was comparable between both groups based on the Kaplan-Meier curves (P = 0.116). HCC: Hepatocellular carcinoma.

Citation: Endo M, Honda K, Tokumaru T, Saito T, Uchida T, Iwao M, Arakawa M, Seike M, Kodama M, Masuda T, Endo Y, Inomata M, Murakami K, Mizukami K. Hepatocellular carcinoma in F0 livers: Clinical and prognostic insights. World J Gastrointest Oncol 2026; 18(4): 115576
URL: https://www.wjgnet.com/1948-5204/full/v18/i4/115576.htm
DOI: https://dx.doi.org/10.4251/wjgo.v18.i4.115576

Endo M, Honda K, Tokumaru T, Saito T, Uchida T, Iwao M, Arakawa M, Seike M, Kodama M, Masuda T, Endo Y, Inomata M, Murakami K, Mizukami K. Hepatocellular carcinoma in F0 livers: Clinical and prognostic insights. World J Gastrointest Oncol 2026; 18(4): 115576 [DOI: 10.4251/wjgo.v18.i4.115576]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.